Archived article. This article was published by Synergus RWE on 04 May 2016 and is kept for reference. For current insights visit athagoras Medtech.
French HTA evalutions
The French Haute Autorité de Santé is one of the HTA organisations in Europe with most publications. 3,6% of their publications are HTA reports and 96,4 % are reimbursement evaluations of individual drugs or technologies.
In the last 12 months, the 3 most frequent companies in the reports have been Sanofi, Pfizer and Roche.
Looking at their evaluations, there is a steady utility of quality of life measures such as EQ-5D and SF-36.
Learn more about our service: http://htasearch.synergus.com/